The US FDA has approved the experimental antibiotic Zerbaxa for the treatment of typical urinary tract infections and intra abdominal infections. The experimental antibiotic Zerbaxa is a product by Cubist Pharmaceuticals Inc. The Federal regulators on Friday approved a new antibiotic which will fight intra-abdominal and urinary tract infections. The antibiotic is being developed by […]
Immune Boosting Drugs Show Promise in Treatment of Hodgkin’s
Encouraging results have been obtained for drugs by Bristol-Myers Squibb Co. and Merck & Co. for treating Hodgkin’s lymphoma. The drug acts by boosting the immune system by blocking a pathway called PD-1 and fight the cancer cells which managed to evade the natural defenses of the body. Another Merck’s drug, Keytruda has been given […]
